Genetic Signatures Limited is a molecular diagnostic company that offers real-time polymerase chain reaction-based products to detect infectious diseases under the brand EasyScreen. The Australian company also develops the MDx 3Base platform technology, which allows hospital and pathology laboratories to screen for various infectious pathogens. Since its establishment in 2001, Genetic Signatures Limited has expanded its operations to North America, Europe, the Middle East, and Africa.